KRAS and colorectal carcinoma: Specifically in CRC, the analysis of 83 patients with paired primary tumors and matched metastases revealed that 25% of the tumors with mutant KRAS and 4% of wild-type KRAS tumors had PIK3CA mutations (P = 0.008) (69).